Golgi-dependent Reactivation and Regeneration of Quiescent Neural Stem Cells
PreprintsMahekta Rajeshkumar Gujar, Yang Gao, Xiang Teng, Qiannan Deng, Ye Sing Tan, Yusuke Toyama, Hongyan Wang
Mahekta Rajeshkumar Gujar, Yang Gao, Xiang Teng, Qiannan Deng, Ye Sing Tan, Yusuke Toyama, Hongyan Wang
Scientists at the Francis Crick Institute have identified a group of latent stem cells that respond to injury in the central nervous system of mice.
Jong-Tae Kim, Sung Min Cho, Dong Hyuk Youn, Tae Yeon Kim, Sung Woo Han, Chan Hum Park, Younghyurk Lee, Eun Pyo Hong, Harry Jung, Jae Jun Lee, Jong Kook Rhim, Jeong Jin Park, Jun Hyong Ahn, Heung Cheol Kim,
Xiuyin Shen, Xin Luo, Shuzhen Wu, Yingchun Wan, Huiting Ma, Shaoxin Ye, Zhuoling Zhang, Min Lu, Hai Tang, Xiaoyan Gou, Xiaoling Guo, ZhengPing Liu
Stephanie Dooves, Liza M.L. Kok, Dwayne B. Holmes, Nicole Breeuwsma, Marjolein Breur, Marianna Bugiani, Nicole Wolf, Vivi M Heine
Ashwani Choudhary, Ritu Nayak, David Peles, Liron Mizrahi, Shani Stern
Shuichi Ozono, Kazuo Sakashita, Nao Yoshida, Harumi Kakuda, Kenichiro Watanabe, Miho Maeda, Yasushi Ishida, Atsushi Manabe, Takashi Taga, Hideki Muramatsu
Alexandra Neaverson, Malin H.L. Andersson, Osama A. Arshad, Luke Foulser, Mary Goodwin-Trotman, Adam Hunter, Ben Newman, Minal Patel, Charlotte Roth, Tristan Thwaites, Helena Kilpinen, Matthew E. Hurles, Andrew Day, Sebastian S. Gerety
Shinta Tominaga, Toshiyasu Ojima, Motoki Miyazawa, Hiromitsu Iwamoto, Junya Kitadani, Shimpei Maruoka, Keiji Hayata, Hiroki Yamaue
With super-resolution imaging, Penn Medicine researchers discovered that cells change the physical structure of their genome when they’re affected by disease
Mabel O Akinyemi, Muyiwa S Adegbaju, Anastasia Grytsay, Osamede H Osaiyuwu, Jessica Finucan, Ibukun M Ogunade, Sunday O Peters, Bolaji N Thomas, Olanrewaju B Morenikeji
Muhammad Irfan, Seung Chung
Xiaoai Zhao, Xin Yan, Kévin Contrepois, Francesco Vallania, Mathew Ellenberger, Chloe M. Kashiwagi, Stephanie D. Gagnon, Cynthia J. Siebrand, Matias Cabruja, Gavin M. Traber, Andrew McKay, Daniel Hornburg, Purvesh Khatri, Michael P.
Katsiaryna Maskalenka, Gokberk Alagoz, Felix Krueger, Joshua Wright, Maria Rostovskaya, Asif Nakhuda, Adam Bendall, Christel Krueger, Simon Walker, Aylwyn Scally, Peter Rugg-Gunn
Chao Chen, Sherin Hashem, Jay Sharma, Ana Maria Manso, Paul Bushway, Jason Duran, Emily Gault, Yusu Gu, Jose Cano Nigenda, Angel Soto-Hermida, Kirk Peterson, Paul Saftig, Stephanie Cherqui, Sylvia Evans,
Pan Luo, Huiyin Qiu, Yushan Yang, Jiaqi Wu, Xianmin Song, Guorong Fan, Gaolin Liu, Junwei Gao
Fei Yan, Meihua Gong, Fu-Rong Li, Li Yu
Dongjin S Shin, Francesco K Touani, Damon G.K Aboud, Anne Kietzig, Sophie Lerouge, Corinne A Hoesli
Kristi Dietert, Swetha Mahesula, Sheetal Hegde, John Verschelde, Pamela Reed, Shane Sprague, Erzsebet Kokovay, Naomi L Sayre
UC San Diego scientists have developed a technology that uses CRISPR genetic editing in Drosophila suzukii, the invasive fruit fly responsible for millions of dollars in fruit crop damage.
It could be the world’s tiniest EEG electrode cap, created to measure activity in a brain model the size of a pen dot. Its designers expect the device to lead to better understanding of neural disorders and how potentially dangerous chemicals affect the brain. This engineering feat, led by Johns Hopkins University researchers and detailed today in Science Advances, expands what researchers can accomplish with organoids, including mini brains—the lab-grown balls of human cells that mimic some of a brain’s structure and functionality.
Homa Majd, Sadaf Amin, Zaniar Ghazizadeh, Andrius Cesiulis, Edgardo Arroyo, Karen Lankford, Sina Farahvashi, Angeline K Chemel, Mesomachukwu Okoye, Megan D Scantlen, Jason Tchieu, Elizabeth L Calder, Valerie LeRouzic, Abolfazl Arab,
Lihui Peng, Julien E Gautrot
Hospital is one of only five in the U.S. selected to participate in early clinical trial for the minimally invasive Impella BTR technology
Leading researchers will gather this week at a Case Western Reserve University-led symposium highlighting progress and opportunities in biomedical research and human-performance sciences. The event takes place this Thursday and Friday, Aug. 18-19, at the Wolstein Research Center on the Case Western Reserve campus, and features researchers and clinicians from the university, area hospital affiliates and the Wright-Patterson Air Force Base in Dayton.
Huachuan Zheng, Hang Xue, Ying E, Zhengguo Cui
Arina A. Nikitina, Alexandria Van Grouw, Tanya Roysam, Danning Huang, Facundo M. Fernandez, Melissa L. Kemp
Jessica Crowe, Lara Edbrooke, Amit Khot, Linda Denehy, Jill J Francis
Omer Jamy, John Dasher, Alice Chen, Donna Salzman, Ravi Bhatia, Smita Bhatia
Sahar I Mostafa, Nesma M Abdelfattah, Sayed M Ghorab, Manal F Osman, Noha A Elwassefy
Koya Obara, Kyoumi Shirai, Yuko Hamada, Nobuko Arakawa, Ayami Hasegawa, Nanao Takaoka, Ryoichi Aki, Robert M. Hoffman, Yasuyuki Amoh
Yi-Xiao Xiong, Xiaochao Zhang, Jing-Han Zhu, Yuxin Zhang, Yonglong Pan, Yu Wu, Jian-Ping Zhao, Junjie Liu, Yuan-Xiang Lu, Huifang Liang, Zhanguo Zhang, Wanguang Zhang
Gesine Bug, Myriam Labopin, Riitta Niittyvuopio, Matthias Stelljes, Christian Reinhardt, Inken Hilgendorf, Nicolaus Kroeger, Ain Kaare, Wolfgang Bethge, Kerstin Schaefer-Eckart, Mareike Verbeek, Stephan Mielke, Kristina Carlson, Ali
Researchers at Karolinska Institutet in Sweden and the Swedish University of Agricultural Sciences have discovered that spider silk proteins can be fused to biologically active proteins and be converted into a gel at body temperature.
Researchers at the Georgia Institute of Technology have found a detection method that could revolutionize cancer treatment by showing how cancers metastasize and what stage they are.
The successful generation of endodermal, ectodermal, and most mesodermal lineages from pluripotent stem cells has resulted in basic discoveries and regenerative medicine clinical trials of cell-based therapies.
: Mesenchymal stromal cells are essential components of hematopoietic stem and progenitor cell (HSPC) niches, regulating HSPC proliferation and fate decisions.
Liangwen Zhong, Miriam Gordillo, Xingyi Wang, Yiren Qin, Yuanyuan Huang, Alexey Soshnev, Ritu Kumar, Gouri Nanjangud, Daylon James, C. David Allis, Todd Evans, Bryce Carey, Duancheng Wen
Zhipeng Sun, Todd Nystul, Guohua Zhong
Jasmine Moshiri, Ailsa Craven, Sara Mixon, Manuel Amieva, Karla Kirkegaard
Guoqiang Yang, Jiraporn Kantapan, Maryam Mazhar, Xue Bai, Yuanxia Zou, Honglian Wang, Bingfeng Huang, Sijing Yang, Nathupakorn Dechsupa, Li Wang
Mayo Clinic today announced a strategic collaboration in biomanufacturing to deliver novel biotherapeutics for rare and complex conditions. The collaboration brings together science, engineering and manufacturing to advance Mayo Clinic's vision of bringing new cures to clinical care. The focus will be on therapies derived from human sources known as biologics — cells, blood, enzymes, tissues, genes or genetically engineered cells — for use in medicines. Therapeutics based on biologics have the potential to target exact tissues needing repair.
Scientists from the Terasaki Institute for Biomedical Innovation (TIBI) have developed a contact lens that can capture and detect exosomes, nanometer-sized vesicles found in bodily secretions which have the potential for being diagnostic cancer biomarkers.
Ehsaneh Azaryan, Samira Karbasi, Mansoore Saharkhiz, Mohammad Yahya Hanafi-Bojd, Asghar Zarban, Fariba Emadian Razavi, Mohsen Naseri
Silvio Ligia, Salvatore Giacomo Morano, Francesca Kaiser, Alessandra Micozzi, Maria Luisa Moleti, Walter Barberi, Fiorina Giona, Antonio Chistolini, Valentina Arena, Alfonso Piciocchi, Maurizio Forgione, Giulia Gasperini, Marco Fabbri, Anna Maria Testi
A new imaging device at UT Southwestern is making complex aortic repairs safer for patients and operating room staff by dramatically reducing their exposure to radiation. The device, known as Fiber Optic RealShape (FORS) and manufactured by Philips, uses light to visualize blood vessels, nearly eliminating the need for X-rays typically used during minimally invasive vascular procedures.
Two biomedical imaging technologies developed with support from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have been cleared for clinical use by the Food and Drug Administration (FDA). Both technologies offer advances in computed tomography (CT).
Mount Sinai Health System and the Icahn School of Medicine at Mount Sinai have launched a new human genome sequencing research project called the Mount Sinai Million Health Discoveries Program with the Regeneron Genetics Center (RGC), part of the industry-leading, New York-based biotechnology company Regeneron.